World's Best Scientists 2026 revealed!
Christian H. Ottensmeier

Christian H. Ottensmeier

D-Index & Metrics

Immunology

D-Index
78
Citations
38681
World Ranking
1714
National Ranking
150

Christian H. Ottensmeier publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Christian H. Ottensmeier sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 309 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Christian H. Ottensmeier D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Christian H. Ottensmeier sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 78 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Christian H. Ottensmeier is affiliated with the University of Southampton in the United Kingdom. Their research spans primarily the fields of Medicine and Immunology and Microbiology, with significant contributions across Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology, and Infectious Diseases.

The main topics of Christian H. Ottensmeier's work include:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Lung Cancer Treatments and Mutations
  • Vaccines and immunoinformatics approaches
  • COVID-19 Clinical Research Studies

Recent publications reflect a focus on immune responses in cancer and infectious diseases. Select papers include:

  • "Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19" (2020), published in Cell
  • "NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors" (2020), Cancer Research
  • "Severely ill patients with COVID-19 display impaired exhaustion features in SARS-CoV-2-reactive CD8 + T cells" (2021), Science Immunology
  • "Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial" (2021), The Lancet Oncology
  • "M1hot tumor-associated macrophages boost tissue-resident memory T cells infiltration and survival in human lung cancer" (2020), Journal for ImmunoTherapy of Cancer

Christian H. Ottensmeier frequently collaborates with several researchers in their field, including:

  • Gareth J. Thomas
  • Pandurangan Vijayanand
  • Serena Chee
  • Adrian von Witzleben
  • Simon Laban

Publication venues where Christian H. Ottensmeier's work appears regularly include:

  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Regular and Young Investigator Award Abstracts
  • Laryngo-Rhino-Otologie

Best Publications

  • Improved Survival with Ipilimumab in Patients with Metastatic Melanoma.

    F. Stephen Hodi;Steven J. O'Day;David F. McDermott;Robert W. Weber

  • Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

    Nicholas McGranahan;Rachel Rosenthal;Crispin T. Hiley;Crispin T. Hiley;Andrew J. Rowan

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Actively personalized vaccination trial for newly diagnosed glioblastoma

    Norbert Hilf;Sabrina Kuttruff-Coqui;Katrin Frenzel;Valesca Bukur

  • Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

    Frederick Arce Vargas;Andrew J S Furness;Kevin Litchfield;Kroopa Joshi

  • Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer

    Anusha-Preethi Ganesan;James Clarke;James Clarke;Oliver Wood;Eva M Garrido-Martin

  • Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4 + T Cells in COVID-19.

    Benjamin J. Meckiff;Ciro Ramírez-Suástegui;Vicente Fajardo;Serena J. Chee

  • DNA vaccines: precision tools for activating effective immunity against cancer.

    Jason Rice;Christian H. Ottensmeier;Freda K. Stevenson

  • Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.

    Frederick Arce Vargas;Andrew J.S. Furness;Andrew J.S. Furness;Isabelle Solomon;Kroopa Joshi;Kroopa Joshi

  • Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer

    M J Ward;S M Thirdborough;T Mellows;C Riley

  • Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.

    Pia Kvistborg;Daisy Philips;Sander Kelderman;Lois Hageman

  • NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors

    Kirsty Ford;Christopher J Hanley;Massimiliano Mellone;Cedric Szyndralewiez

  • Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma

    Delin Zhu;Helen McCarthy;Christian H. Ottensmeier;Peter Johnson

  • Binding of Ovarian Cancer Cells to Peritoneal Mesothelium in Vitro Is Partly Mediated by CD44H

    Stephen A. Cannistra;Geoffrey S. Kansas;Jonathan Niloff;Brenda DeFranzo

  • Geospatial immune variability illuminates differential evolution of lung adenocarcinoma

    Khalid AbdulJabbar;Shan E. Ahmed Raza;Rachel Rosenthal;Rachel Rosenthal;Mariam Jamal-Hanjani;Mariam Jamal-Hanjani

  • A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors

    Eric E. Angevin;Josep Tabernero;Elena E. Elez;Steven Cohen

  • Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8 + T cells.

    Anthony Kusnadi;Ciro Ramírez-Suástegui;Vicente Fajardo;Serena J Chee

  • Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer.

    James Clarke;James Clarke;Bharat Panwar;Ariel Madrigal;Divya Singh

  • Response definition criteria for ELISPOT assays revisited.

    Z. Moodie;L. Price;C. Gouttefangeas;A Mander

  • Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression.

    Christian H. Ottensmeier;Andrew R. Thompsett;Delin Zhu;Bridget S. Wilkins

  • Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

    Susanna Mandruzzato;Sven Brandau;Cedrik M. Britten;Cedrik M. Britten;Vincenzo Bronte

  • DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer.

    Lindsey Low;Ann Mander;Katy McCann;David Dearnaley

Frequent Co-Authors

Pandurangan Vijayanand
Pandurangan Vijayanand La Jolla Institute For Allergy & Immunology
Freda K. Stevenson
Freda K. Stevenson University of Southampton
Paul Lorigan
Paul Lorigan University of Manchester
Sjoerd H. van der Burg
Sjoerd H. van der Burg Leiden University Medical Center
Marij J. P. Welters
Marij J. P. Welters Leiden University Medical Center
Grégory Seumois
Grégory Seumois La Jolla Institute For Allergy & Immunology
Ugur Sahin
Ugur Sahin Johannes Gutenberg University of Mainz
Hans-Georg Rammensee
Hans-Georg Rammensee University of Tübingen
Peter Johnson
Peter Johnson University of Southampton
Ferhat Ay
Ferhat Ay La Jolla Institute For Allergy & Immunology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, there are several complementary online degree options that can help build a diverse skill set and open doors to various healthcare careers. Nursing programs are a popular choice, offering a direct path to clinical roles. If you’re looking for flexible entry points, the easiest accelerated nursing programs to get into provide fast-tracked opportunities to become a Registered Nurse (RN).

For individuals seeking foundational clinical experience, easy LPN programs to get into offer practical nursing education with accessible admission criteria. These programs can serve as stepping stones towards more advanced nursing careers or specialized immunology-related roles.

Advancing further, nurse practitioner degrees combine deep clinical knowledge with leadership skills. Programs described as nurse practitioner programs with easy admission make it feasible to enter advanced practice nursing, complementing immunology studies.

Additionally, for those interested in mental health within immunology contexts, best pmhnp programs online offer highly rated clinical placements, preparing graduates for specialized roles as Psychiatric Mental Health Nurse Practitioners. These career pathways highlight the interdisciplinary opportunities available to immunology students in the USA.

Best Scientists Citing Christian H. Ottensmeier

Trending Scientists

Recently Published Articles